These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 2507471)
1. 2-Deoxy-D-glucose inhibits the antitumor effects of alpha-difluoromethylornithine on the growth of colon cancer in vivo. Saydjari R; Upp JR; Alexander RW; Barranco SC; Townsend CM; Thompson JC Invest New Drugs; 1989 Jul; 7(2-3):131-8. PubMed ID: 2507471 [TBL] [Abstract][Full Text] [Related]
2. The effects of 2-deoxy-D-glucose and alpha-difluoromethylornithine on the growth of pancreatic cancer in vivo. Saydjari R; Alexander RW; Barranco SC; Townsend CM; Thompson JC Pancreas; 1989; 4(1):38-43. PubMed ID: 2497460 [TBL] [Abstract][Full Text] [Related]
3. Differential sensitivity of pancreatic and colon cancer to cyclosporine and alpha-difluoromethylornithine in vivo. Saydjari R; Townsend CM; Barranco SC; Thompson JC Invest New Drugs; 1988 Dec; 6(4):265-72. PubMed ID: 3147968 [TBL] [Abstract][Full Text] [Related]
4. Cyclosporine and alpha-difluoromethylornithine exhibit differential effects on colon and pancreatic cancer in vitro. Saydjari R; Townsend CM; Barranco SC; Thompson JC Invest New Drugs; 1987; 5(3):251-8. PubMed ID: 3117720 [TBL] [Abstract][Full Text] [Related]
5. Effects of cyclosporine and alpha-difluoromethylornithine on the growth of mouse colon cancer in vitro. Saydjari R; Townsend CM; Barranco SC; Thompson JC Life Sci; 1987 Jan; 40(4):359-66. PubMed ID: 3100897 [TBL] [Abstract][Full Text] [Related]
6. Differential sensitivity of various human tumors to inhibition of polyamine biosynthesis in vivo. Saydjari R; Alexander RW; Upp JR; Barranco SC; Townsend CM; Thompson JC Int J Cancer; 1991 Jan; 47(1):44-8. PubMed ID: 1985877 [TBL] [Abstract][Full Text] [Related]
7. [Antitumor effect of alpha-difluoromethylornithine (DFMO) changes in ornithine decarboxylase (ODC) activity and polyamine (PA) levels in human tumor transplanted into nude mice]. Umemoto S Nihon Geka Gakkai Zasshi; 1989 May; 90(5):650-60. PubMed ID: 2507897 [TBL] [Abstract][Full Text] [Related]
8. The effect of tumor burden on ornithine decarboxylase activity in mice. Saydjari R; Alexander RW; Upp JR; Poston GJ; Barranco SC; Townsend CM; Thompson JC Cancer Invest; 1991; 9(4):415-9. PubMed ID: 1884248 [TBL] [Abstract][Full Text] [Related]
9. Effect of alpha-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention. Meyskens FL; Gerner EW; Emerson S; Pelot D; Durbin T; Doyle K; Lagerberg W J Natl Cancer Inst; 1998 Aug; 90(16):1212-8. PubMed ID: 9719082 [TBL] [Abstract][Full Text] [Related]
10. In vivo effects of 4-amidinoindan-1-one 2'-amidinohydrazone (CGP 48664A) and alpha-difluoromethylornithine (DFMO) on L1210 growth, cell-cycle phase distribution and polyamine contents. Dorhout B; te Velde RJ; Ferwerda H; Kingma AW; de Hoog E; Muskiet FA Int J Cancer; 1995 Sep; 62(6):738-42. PubMed ID: 7558423 [TBL] [Abstract][Full Text] [Related]
11. Tumor angiogenesis and polyamines: alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits B16 melanoma-induced angiogenesis in ovo and the proliferation of vascular endothelial cells in vitro. Takigawa M; Enomoto M; Nishida Y; Pan HO; Kinoshita A; Suzuki F Cancer Res; 1990 Jul; 50(13):4131-8. PubMed ID: 1693880 [TBL] [Abstract][Full Text] [Related]
12. [Inhibition by polyamine biosynthesis inhibitor DFMO of the growth of transplanted human colon cancer in nude mice]. Wang M Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):335-7. PubMed ID: 1782843 [TBL] [Abstract][Full Text] [Related]
14. Effects of alpha-difluoromethylornithine on the growth of experimental Wilms' tumor and renal adenocarcinoma. Kingsnorth AN; McCann PP; Diekema KA; Ross JS; Malt RA Cancer Res; 1983 Sep; 43(9):4031-4. PubMed ID: 6307502 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of ornithine decarboxylase with 2-difluoromethylornithine: reduced incidence of dimethylhydrazine-induced colon tumors in mice. Kingsnorth AN; King WW; Diekema KA; McCann PP; Ross JS; Malt RA Cancer Res; 1983 Jun; 43(6):2545-9. PubMed ID: 6406047 [TBL] [Abstract][Full Text] [Related]
16. Antimetastatic activity of DL-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, in mice. Sunkara PS; Rosenberger AL Cancer Res; 1987 Feb; 47(4):933-5. PubMed ID: 3100031 [TBL] [Abstract][Full Text] [Related]
17. Phospho-sulindac (OXT-328) combined with difluoromethylornithine prevents colon cancer in mice. Mackenzie GG; Ouyang N; Xie G; Vrankova K; Huang L; Sun Y; Komninou D; Kopelovich L; Rigas B Cancer Prev Res (Phila); 2011 Jul; 4(7):1052-60. PubMed ID: 21464038 [TBL] [Abstract][Full Text] [Related]
18. Effects of alpha-difluoromethylornithine and recombinant interferon-alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice. Heston WD; Fleischmann J; Tackett RE; Ratliff TL Cancer Res; 1984 Aug; 44(8):3220-5. PubMed ID: 6430546 [TBL] [Abstract][Full Text] [Related]
19. Dose de-escalation chemoprevention trial of alpha-difluoromethylornithine in patients with colon polyps. Meyskens FL; Emerson SS; Pelot D; Meshkinpour H; Shassetz LR; Einspahr J; Alberts DS; Gerner EW J Natl Cancer Inst; 1994 Aug; 86(15):1122-30. PubMed ID: 8028034 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of polyamine homologues on the prevention of DL-alpha-difluoromethylornithine-mediated inhibition of malignant cell growth and normal immune response. Singh AB; Thomas TJ; Thomas T; Singh M; Mann RA Cancer Res; 1992 Apr; 52(7):1840-7. PubMed ID: 1551114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]